Q BioMed
NY - New YorkBiotechnology
Focus: Q BioMed is a private biotechnology company headquartered in New York that specializes in acquiring and accelerating development of pharmaceutical assets. The company operates as a specialized acquirer focused on existing drug programs rather than de novo discovery.
Profile data last refreshed 53m ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About Q BioMed
AI assessmentNot HiringNo open roles listed right now. Follow Q BioMed to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Q BioMed's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
LOE Approaching
NDA-approved product approaching loss of exclusivity; revenue trajectory likely contractual as generic/biosimilar competition materializes.
Help build intelligence for Q BioMed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.